Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice

References

• CohenSRGardnerTWDiabetic retinopathy and diabetic macular edemaDev Ophthalmol20165513714626501152
   PubMedGoogle Scholar
• CheungNMitchellPWongTYDiabetic retinopathyLancet2010376973512413620580421
   PubMed Web of Science ®Google Scholar
• DingJWontTYCurrent epidemiology of diabetic retinopathy and diabetic macular edemaCurr Diab Rep201212434635422585044
   PubMed Web of Science ®Google Scholar
• LeeRWongTYSabanayagamCEpidemiology of diabetic retinopathy, diabetic macular edema and related vision lossEye Vis (Lond)201521726605370
   PubMedGoogle Scholar
• Executive SummaryIFD Diabetes Atlas7th edition Available from: http://www.diabetesatlas.org/Accessed July 9, 2017
   Google Scholar
• BandelloFCicinelliMVParodiMBAnti-VEGF molecules for the management of diabetic macular edemaCurr Pharm Des201521324731473726350530
   PubMed Web of Science ®Google Scholar
• FogliSMogaveroSEganCGDel ReMDanesiRPathophysiology and pharmacological targets of VEGF in diabetic macular edemaPharmacol Res201610314915726607863
   PubMed Web of Science ®Google Scholar
• StewartMWThe expanding role of vascular endothelial growth factor inhibitors in ophthalmologyMayo Clin Proc2012871778822212972
   PubMed Web of Science ®Google Scholar
• SimóRSundstromJMAntonettiDAOcular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathyDiabetes Care201437489389924652720
   PubMed Web of Science ®Google Scholar
• AjlanRSSilvaPSSunJKVascular endothelial growth factor and diabetic retinal diseaseSemin Ophthalmol2016311–2404826959128
   PubMed Web of Science ®Google Scholar
• VirgiliGParravanoMMenchiniFBrunettiMAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular edemaCochrane Database Syst Rev201212CD007419
   Google Scholar
• BandelloFBerchicciLLa SpinaCBattaglia ParodiMIaconoPEvidence for anti-VEGF treatment of diabetic macular edemaOphthalmic Res201248Suppl 1162022907145
   PubMed Web of Science ®Google Scholar
• GoyalSLavalleyMSubramanianMLMeta-analysis and review on the effect of bevacizumab in diabetic macular edemaGraefes Arch Clin Exp Ophthalmol20112491152720665044
   PubMed Web of Science ®Google Scholar
• YilmazTCordero-ComaMGallagherMJTeasleyLASystematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular edemaActa Ophthalmol201189870971720645926
   PubMed Web of Science ®Google Scholar
• DervenisNMikropoulouAMTranosPDervenisPRanibizumab in the treatment of diabetic macular edema: a review of the current status, unmet needs, and emerging challengesAdv Ther20173461270128228484955
   PubMed Web of Science ®Google Scholar
• AbouammohMARanibizumab injection for diabetic macular edema: meta-analysis of systemic safety and systematic reviewCan J Ophthalmol201348431732323931473
   PubMed Web of Science ®Google Scholar
• ChangAAHongTEweSYBahramiBBroadheadGKThe role of aflibercept in the management of diabetic macular edemaDrug Des Devel Ther2015943894396
   PubMed Web of Science ®Google Scholar
• HarkinsKAHaschkeMDoDVAflibercept for the treatment of diabetic macular edemaImmunotherapy20168550351026907516
   PubMed Web of Science ®Google Scholar
• KeatingGMAflibercept: a review of its use in diabetic macular edemaDrugs201575101153116026056030
   PubMed Web of Science ®Google Scholar
• MoradiASepahYJSadiqMAVascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edemaWorld J Diabetes20134630330924379921
   PubMedGoogle Scholar
• KorobelnikJFKleijnenJLangSHSystematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)BMC Ophthalmol2015155225975823
   PubMed Web of Science ®Google Scholar
• DeisslerHLLangGKLangGECapacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cellsExp Eye Res2014122203124631334
   PubMed Web of Science ®Google Scholar
• StewartMWRosenfeldPJPredicted biological activity of intravitreal VEGF TrapBr J Ophthalmol200892566766818356264
   PubMed Web of Science ®Google Scholar
• KorobelnikJFDoDVSchmidt-ErfurthUIntravitreal aflibercept for diabetic macular edemaOphthalmology2014121112247225425012934
   PubMed Web of Science ®Google Scholar
• BrownDMSchmidt-ErfurthUDoDVIntravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studiesOphthalmology2015122102044205226198808
   PubMed Web of Science ®Google Scholar
• HeierJSKorobelnikJFBrownDMIntravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studiesOphthalmology2016123112376238527651226
   PubMed Web of Science ®Google Scholar
• The Diabetic Retinopathy Clinical Research NetworkAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med20153721193120325692915
   PubMed Web of Science ®Google Scholar
• KonidarisVETsaousisKTAl-HubeshyZPieriKDeaneJEmpeslidisTClinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular edemaEye (Lond)201731111629163028622326
   PubMed Web of Science ®Google Scholar
• BahramiBHongTZhuMSchlubTEChangASwitching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edemaGraefes Arch Clin Exp Ophthalmol201725561133114028238195
   PubMed Web of Science ®Google Scholar
• CălugăruDCălugăruMSwitching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edemaGraefes Arch Clin Exp Ophthalmol201725571451145228389701
   PubMed Web of Science ®Google Scholar
• LimLSNgWYMathurRConversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumabClin Ophthalmol201591715171826396494
   PubMed Web of Science ®Google Scholar
• WoodEHKarthPAMoshfeghiDMLengTShort-term outcomes of aflibercept therapy for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumabOphthalmic Surg Lasers Imaging Retina201546995095426469235
   PubMed Web of Science ®Google Scholar
• MiraFPauloMHenriquesFFigueiraJSwitch to aflibercept in diabetic macular edema patients unresponsive to previous anti-VEGF therapyJ Ophthalmol20172017563263428348885
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research GroupGrading diabetic retinopathy from stereoscopic color fundus photographs an extension of the modified Airlie House classification. ETDRS report number 10Ophthalmology1991985 Suppl7868062062513
   PubMed Web of Science ®Google Scholar
• FoudaSMBahgatAMIntravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edemaClin Ophthalmol20171156757128356711
   PubMed Web of Science ®Google Scholar